Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Molecular Medicine Congress

Enal Razvi's Biography



Enal Razvi, Managing Director, Select Biosciences Inc

Enal Razvi, PhD is biotechnology analyst and Managing Director US at Select Biosciences. In this capacity he continuously tracks a number of fields in the scope of his industry coverage, authors market analysis reports in these areas, and works with companies worldwide in the areas of technology analysis, market research, strategy development, and operational roles. Dr. Razvi holds a doctoral degree in the biomedical sciences and was post-doctoral fellow under Ralph Steinman [Nobel Laureate in 2011] at The Rockefeller University, New York. For the last decade, Dr. Razvi has been focused on tracking the life sciences fields and has worked with numerous companies around the world.

Dr. Razvi can be reached at: enal@selectbio.us

Enal Razvi Image

The Worldwide Market Landscape for Exosomes: Research and Translational Opportunities

Tuesday, 3 September 2013 at 10:35

Add to Calendar ▼2013-09-03 10:35:002013-09-03 11:35:00Europe/LondonThe Worldwide Market Landscape for Exosomes: Research and Translational OpportunitiesMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com

SELECTBIO has been tracking the qualitative and quantitative trends and opportunities in the exosomes and microvesicles marketplace. In this presentation, I provide an up-to-date snapshot of this evolving marketplace excerpted from SELECTBIO's various market reports on this topic. Presented are technologies for exosome analysis, segmentation of the exosome research market, market penetrance of various approaches for exosome study, disciplines/disease areas where exosome research is currently being carried out, and sizes of some of the market segments in this space—both from a basic research and a translational standpoint.

Mapping the Market for Cancer Biomarkers, Epigenetic, and miR Biomarkers

Tuesday, 3 September 2013 at 10:45

Add to Calendar ▼2013-09-03 10:35:002013-09-03 11:35:00Europe/LondonThe Worldwide Market Landscape for Exosomes: Research and Translational OpportunitiesMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com

SELECTBIO has been tracking the marketplace for various emerging biomarker classes, most notably epigenetic biomarkers and microRNA biomarkers.  In this presentation, I will frame the technology trends and market landscape for these novel classes of cancer biomarkers, and frame the opportunity in terms of "hotspots" of research and commercial activity.

Mapping the Market for Cancer Biomarkers, Epigenetic, and miR Biomarkers

Tuesday, 3 September 2013 at 10:45

Add to Calendar ▼2013-09-03 10:35:002013-09-03 11:35:00Europe/LondonThe Worldwide Market Landscape for Exosomes: Research and Translational OpportunitiesMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com

SELECTBIO has been tracking the marketplace for various emerging biomarker classes, most notably epigenetic biomarkers and microRNA biomarkers.  In this presentation, I will frame the technology trends and market landscape for these novel classes of cancer biomarkers, and frame the opportunity in terms of "hotspots" of research and commercial activity.


Add to Calendar ▼2013-09-03 00:00:002013-09-04 00:00:00Europe/LondonMolecular Medicine CongressMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com